Barnes & Noble
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Barnes & Noble's revenues will grow 4.6% and EPS will remain in the red.
The average estimate for revenue is $1.48 billion. On the bottom line, the average EPS estimate is -$1.14.
Last quarter, Barnes & Noble reported revenue of $1.38 billion. GAAP reported sales were 0.4% higher than the prior-year quarter's $1.37 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.53. GAAP EPS were -$1.08 for Q4 against -$1.04 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 28.9%, 150 basis points better than the prior-year quarter. Operating margin was -5.1%, 50 basis points better than the prior-year quarter. Net margin was -4.2%, 10 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $7.47 billion. The average EPS estimate is -$0.78.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 296 members out of 649 rating the stock outperform, and 353 members rating it underperform. Among 174 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 56 give Barnes & Noble a green thumbs-up, and 118 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Barnes & Noble is hold, with an average price target of $15.00.
If you're invested in retailers like Barnes & Noble, you should check out the concept that is The Motley Fool's top stock for 2012. Its founder wrote the book on big box retailing, and it's growing in increasingly important international markets. Click here for instant access to this free report.
- Add Barnes & Noble to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Great Reasons to Sell Barnes & Noble, Inc. Stock
The beleaguered bookseller continues to disappoint investors.
What Happened in the Stock Market Today
Stocks continued their strong start to 2018. Holiday sales at Barnes & Noble disappointed investors, though, and Momenta Pharmaceuticals reported a successful drug trial.
Why Barnes & Noble, Inc. Stock Plunged Today
The bookselling retail chain endured a difficult holiday season. Here's what investors need to know.